NCT03521947

Brief Summary

Pancytopenia is an important hematologic Problem.it is a decrease in all three cellular elements of peripheral blood leading to aneamia, leucopenia and thrombocytopenia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

1 year

First QC Date

April 17, 2018

Last Update Submit

May 9, 2018

Conditions

Keywords

MCP

Outcome Measures

Primary Outcomes (1)

  • Availability

    Bone marrow examination for all cases \[evaluate the causes of pancytopenia and plan further investigations and treatment.\]

    One year

Secondary Outcomes (1)

  • Modification

    One year

Study Arms (1)

One group of children below 18 years old

Diagnostic Test: Complete blood picture

Interventions

Complete blood pictureDIAGNOSTIC_TEST

Iaboratory investigation

One group of children below 18 years old

Eligibility Criteria

Age4 Weeks - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Childrens and adolescents from age one month up to 18 years old suffering from pancytopenia.

You may qualify if:

  • All childrens and adolescents suffering from pancytopenia attending heamatology unit of pediatric department Assiut University Hospital will be included.

You may not qualify if:

  • childrens and adolescents suffering from pancytopenia due to malignancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Hayat,A.S, Khan,A.H,GH and Shaikh, N . (2014). Pancytopenia :study for clinical features and Etiological pattern at a tertiary care settings in Abbottabad.The professional medical journal, 21,060-065.

    BACKGROUND
  • Raja S, Suman FR, Scott JX, Latha MS, Rajenderan A, Ethican A. Pancytopenia - (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia. South Asian J Cancer. 2015 Apr-Jun;4(2):68-71. doi: 10.4103/2278-330X.155648.

    PMID: 25992344BACKGROUND
  • Desalphine M, Bagga PK, Gupta PK, Kataria AS. To evaluate the role of bone marrow aspiration and bone marrow biopsy in pancytopenia. J Clin Diagn Res. 2014 Nov;8(11):FC11-5. doi: 10.7860/JCDR/2014/9042.5169. Epub 2014 Nov 20.

    PMID: 25584228BACKGROUND
  • Al-Khalisi, K.A,Al-zubaidy, A. S and Rhaima. M. 2011.Pancytopenia adult patients atBaghdad Teatching Hospital. The Iraqi postgraduate medical journals, 10,441-448

    BACKGROUND

MeSH Terms

Conditions

Pancytopenia

Condition Hierarchy (Ancestors)

CytopeniaHematologic DiseasesHemic and Lymphatic Diseases

Central Study Contacts

Ahmed Gadelrab Askr, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor of pediatrics

Study Record Dates

First Submitted

April 17, 2018

First Posted

May 11, 2018

Study Start

June 1, 2018

Primary Completion

June 1, 2019

Study Completion

December 1, 2019

Last Updated

May 11, 2018

Record last verified: 2018-05